Literature DB >> 10738921

Basal lamina abnormality in the skeletal muscle of Walker-Warburg syndrome.

J Vajsar1, C Ackerley, D Chitayat, L E Becker.   

Abstract

The basal lamina of skeletal muscle fibers has been reported to be thinned and disrupted in patients with Fukuyama and laminin-alpha-2-deficient congenital muscular dystrophies. The basal lamina is normal in other, later-onset, muscular dystrophies, but the plasma membrane is disrupted. It is unknown whether the dystrophic process in Walker-Warburg syndrome (WWS) is characterized by a basal laminal abnormality, a sarcolemmal abnormality, or both. The present study examined the skeletal muscle of a 3-month-old patient with WWS by immunohistochemistry and electron microscopy and compared the findings with control muscle samples. In control samples the basal lamina of skeletal muscle fibers was a continuous, uniformly dense structure associated with sarcolemma. In WWS the basal lamina appeared deranged, with disruptions in nonnecrotic muscle fibers. Furthermore, in some fibers the basal lamina was thinner, and in others, it was duplicated. Dystrophin, laminin-alpha-2, and adhalin stains revealed normal immunoreactivity. The disruptions in the basal lamina may play a primary role in the degeneration of muscle fibers in WWS. When compared with the dystrophies with a primary sarcolemmal defect, it appears that those with primary basal lamina abnormalities (WWS, laminin-alpha-2-deficient, and Fukuyama congenital muscular dystrophies) present early in life, and the phenotype is more severe.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738921     DOI: 10.1016/s0887-8994(99)00129-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  3 in total

1.  ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.

Authors:  Tobias Willer; Hane Lee; Mark Lommel; Takako Yoshida-Moriguchi; Daniel Beltran Valero de Bernabe; David Venzke; Sebahattin Cirak; Harry Schachter; Jiri Vajsar; Thomas Voit; Francesco Muntoni; Andrea S Loder; William B Dobyns; Thomas L Winder; Sabine Strahl; Katherine D Mathews; Stanley F Nelson; Steven A Moore; Kevin P Campbell
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

2.  Human embryoid bodies as a 3D tissue model of the extracellular matrix and α-dystroglycanopathies.

Authors:  Alec R Nickolls; Michelle M Lee; Kristen Zukosky; Barbara S Mallon; Carsten G Bönnemann
Journal:  Dis Model Mech       Date:  2020-06-26       Impact factor: 5.758

Review 3.  The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy.

Authors:  Alec R Nickolls; Carsten G Bönnemann
Journal:  Dis Model Mech       Date:  2018-12-19       Impact factor: 5.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.